Effect of an anesthesia with propofol compared with desflurane on free radical production and liver function after partial hepatectomy

Fundamental and Clinical Pharmacology

Volumn 26, Issue 6, 2012, Pages 735-742

  Laviolle, Bruno ^a,b   Basquin, Cédric ^a   Aguillon, David ^a   Compagnon, Philippe ^a   Morel, Isabelle ^a   Turmel, Valérie ^a,b   Seguin, Philippe ^a   Boudjema, Karim ^a   Bellissant, Eric ^a,b   Mallédant, Yannick ^a  

^a UNIVERSITÉ DE RENNES 1   (France)

^b UNIVERSITÉ DE RENNES 1   (France)

Author keywords

Alpha glutathione S transferase; Desflurane; Hepatectomy; Malondialdehyde; Monoethylglycinexylidide; Propofol

Indexed keywords

ATRACURIUM BESILATE; BLOOD CLOTTING FACTOR 5; DEETHYLLIDOCAINE; DESFLURANE; FIBRINOGEN; FREE RADICAL; GLUTATHIONE TRANSFERASE ALPHA; LIDOCAINE; MALONALDEHYDE; PROPOFOL; SUFENTANIL; THIOPENTAL;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANESTHESIA INDUCTION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE TITRATION; FEMALE; HUMAN; INTRAOPERATIVE PERIOD; INTRAVENOUS ANESTHESIA; LIVER FUNCTION; LIVER INJURY; LIVER METABOLISM; LIVER PROTECTION; LIVER TUMOR; MALE; OXIDATIVE STRESS; PARTIAL HEPATECTOMY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTHROMBIN TIME; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

AGED; ANESTHETICS, INHALATION; FEMALE; FREE RADICALS; HEPATECTOMY; HUMANS; ISOFLURANE; LIDOCAINE; LIVER; LIVER FUNCTION TESTS; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; PROPOFOL; PROSPECTIVE STUDIES; RECOVERY OF FUNCTION; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 84868001453     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2011.00958.x     Document Type: Article

References (38)

1. Kahraman S., Demiryurek A.T. Propofol is a peroxynitrite scavenger. Anesth. Analg. (1997) 84 1127-1129.
2. Murphy P.G., Myers D.S., Davies M.J. et al. The antioxidant potential of propofol (2, 6-diisopropylphenol). Br. J. Anaesth. (1992) 68 613-618.
3. Aldemir O., Celebi H., Cevik C. et al. The effects of propofol or halothane on free radical production after tourniquet induced ischaemia-reperfusion injury during knee arthroplasty. Acta Anaesthesiol. Scand. (2001) 45 1221-1225.
4. Babacan A., Ayhan G., Akcabay M. et al. Assessment of total intravenous anesthesia in renal transplantation. Transplant. Proc. (1998) 30 750-753.
5. Uchinami M., Muraoka R., Horiuchi T. et al. Effect of intermittent hepatic pedicle clamping on free radical generation in the rat liver. Surgery (1998) 124 49-56.
6. Jaeschke H., Farhood A. Neutrophil and Kupffer cell-induced oxidant stress and ischemia-reperfusion injury in rat liver. Am. J. Physiol. (1991) 260 G355-G362.
7. Lee C.J., Subeq Y.M., Lee R.P. et al. Low-dose propofol ameliorates haemorrhagic shock-induced organ damage in conscious rats. Clin. Exp. Pharmacol. Physiol. (2008) 35 766-774.
8. Tsao C.M., Ho S.T., Chen A. et al. Propofol ameliorates liver dysfunction and inhibits aortic superoxide level in conscious rats with endotoxic shock. Eur. J. Pharmacol. (2003) 477 183-193.
9. Shimono H., Goromaru T., Kadota Y. et al. Propofol displays no protective effect against hypoxia/reoxygenation injury in rat liver slices. Anesth. Analg. (2003) 97 442-448.
10. Lorsomradee S., Cromheecke S., De Hert S.G. Effects of sevoflurane on biomechanical markers of hepatic and renal dysfunction after coronary artery surgery. J. Cardiothorac. Vasc. Anesth. (2006) 20 684-690.
11. Chen T.L., Chang H.C., Chen T.G. et al. Modulation of cytochrome P-450 dependent monooxygenases in streptozotocin-induced diabetic hamster: I. Effects of propofol on defluorination and cytochrome P-450 activities. Acta Anaesthesiol. Sin. (2000) 38 15-21.
12. Hamaoka N., Oda Y., Hase I. et al. Propofol decreases the clearance of midazolam by inhibiting CYP3A4: an in vivo and in vitro study. Clin. Pharmacol. Ther. (1999) 66 110-117.
13. Chen T.L., Wu C.H., Chen T.G. et al. Effects of propofol on functional activities of hepatic and extrahepatic conjugation enzyme systems. Br. J. Anaesth. (2000) 84 771-776.
14. Yagi K. Simple assay for the level of total lipid peroxides in serum or plasma. Methods Mol. Biol. (1998) 108 101-106.
15. Conti F., Dousset B., Cherruau B. et al. Use of lidocaine metabolism to test liver function during the long-term follow-up of liver transplant recipients. Clin. Transplant. (2004) 18 235-241.
16. Boudjema K., Veilhan L.A., Dupont-Bierre E. et al. [Two tapes to control the main fissure of the liver]. Ann. Chir. (2002) 127 149-153.
17. Kahraman S., Kilinc K., Dal D. et al. Propofol attenuates formation of lipid peroxides in tourniquet-induced ischaemia-reperfusion injury. Br. J. Anaesth. (1997) 78 279-281.
18. Belghiti J., Noun R., Malafosse R. et al. Continuous versus intermittent portal triad clamping for liver resection: a controlled study. Ann. Surg. (1999) 229 369-375.
19. Figueras J., Llado L., Ruiz D. et al. Complete versus selective portal triad clamping for minor liver resections: a prospective randomized trial. Ann. Surg. (2005) 241 582-590.
20. Petrowsky H., McCormack L., Trujillo M. et al. A prospective, randomized, controlled trial comparing intermittent portal triad clamping versus ischemic preconditioning with continuous clamping for major liver resection. Ann. Surg. (2006) 244 921-928; discussion 928-930.
21. Chan K.C., Lin C.J., Lee P.H. et al. Propofol attenuates the decrease of dynamic compliance and water content in the lung by decreasing oxidative radicals released from the reperfused liver. Anesth. Analg. (2008) 107 1284-1289.
22. Kim S.K., Jee D., Kim J.Y. et al. Effects of propofol on early phase of warm hepatic ischemia/reperfusion injury. Hepatogastroenterology (2007) 54 2333-2336.
23. Allaouchiche B., Debon R., Goudable J. et al. Oxidative stress status during exposure to propofol, sevoflurane and desflurane. Anesth. Analg. (2001) 93 981-985.
24. Sedlic F., Pravdic D., Ljubkovic M. et al. Differences in production of reactive oxygen species and mitochondrial uncoupling as events in the preconditioning signaling cascade between desflurane and sevoflurane. Anesth. Analg. (2009) 109 405-411.
25. Kaplan N., Yagmurdur H., Kilinc K. et al. The protective effects of intravenous anesthetics and verapamil in gut ischemia/reperfusion-induced liver injury. Anesth. Analg. (2007) 105 1371-1378.
26. Yagmurdur H., Cakan T., Bayrak A. et al. The effects of etomidate, thiopental, and propofol in induction on hypoperfusion-reperfusion phenomenon during laparoscopic cholecystectomy. Acta Anaesthesiol. Scand. (2004) 48 772-777.
27. Suehiro T., Matsumata T., Shikada Y. et al. Change in alpha glutathione s-transferase levels during liver resection. Hepatogastroenterology (2004) 51 1747-1750.
28. Chouker A., Martignoni A., Schauer R.J. et al. Alpha-gluthathione S-transferase as an early marker of hepatic ischemia/reperfusion injury after liver resection. World J. Surg. (2005) 29 528-534.
29. Beckett G.J., Hayes J.D. Glutathione S-transferases: biomedical applications. Adv. Clin. Chem. (1993) 30 281-380.
30. Hayes P.C., Bouchier I.A., Beckett G.J. Glutathione S-transferase in humans in health and disease. Gut (1991) 32 813-818.
31. Rohm K.D., Suttner S.W., Boldt J. et al. Insignificant effect of desflurane-fentanyl-thiopental on hepatocellular integrity - a comparison with total intravenous anaesthesia using propofol-remifentanil. Eur. J. Anaesthesiol. (2005) 22 209-214.
32. Ko J.S., Gwak M.S., Choi S.J. et al. The effects of desflurane and propofol-remifentanil on postoperative hepatic and renal functions after right hepatectomy in liver donors. Liver Transpl. (2008) 14 1150-1158.
33. Oellerich M., Armstrong V.W. The MEGX test: a tool for the real-time assessment of hepatic function. Ther. Drug Monit. (2001) 23 81-92.
34. Yang L.Q., Yu W.F., Cao Y.F. et al. Potential inhibition of cytochrome P450 3A4 by propofol in human primary hepatocytes. World J. Gastroenterol. (2003) 9 1959-1962.
35. Isohanni M.H., Neuvonen P.J., Palkama V.J. et al. Effect of erythromycin and itraconazole on the pharmacokinetics of intravenous lignocaine. Eur. J. Clin. Pharmacol. (1998) 54 561-565.
36. Isohanni M.H., Neuvonen P.J., Olkkola K.T. Effect of fluvoxamine and erythromycin on the pharmacokinetics of oral lidocaine. Basic Clin. Pharmacol. Toxicol. (2006) 99 168-172.
37. Olkkola K.T., Isohanni M.H., Hamunen K. et al. The effect of erythromycin and fluvoxamine on the pharmacokinetics of intravenous lidocaine. Anesth. Analg. (2005) 100 1352-1356.
38. O'Keeffe N.J., Healy T.E. The role of new anesthetic agents. Pharmacol. Ther. (1999) 84 233-248.